Skip to main content
. 2015 Oct 12;47(6):2082–2090. doi: 10.3892/ijo.2015.3196

Figure 3.

Figure 3

Rates of Helios+ Foxp3+, Helios Foxp3+ cells among CD4+ T cells of HD and NSCLC. Data of HD and NSCLC patients in panels (A and B) were divided into four groups: preoperative stage IA; preoperative stage ≥IB; 1st or 2nd line chemotherapy; and ≥3rd line or more chemotherapy for recurrence in panels (C and D), respectively. Mean ± SEM. HD, healthy donors; NSCLC, non-small cell lung cancer patients; *P<0.05; **P<0.01.